SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Morgan J P & Co Inc – ‘10-K’ for 12/31/99 – EX-27

On:  Wednesday, 3/8/00   ·   For:  12/31/99   ·   Accession #:  950123-0-2072   ·   File #:  1-05885

Previous ‘10-K’:  ‘10-K’ on 3/11/99 for 12/31/98   ·   Latest ‘10-K’:  This Filing

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of                Filer                Filing    For·On·As Docs:Size              Issuer               Agent

 3/08/00  Morgan J P & Co Inc               10-K       12/31/99    7:587K                                   RR Donnelley/FA

Annual Report   —   Form 10-K
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-K        J.P. Morgan & Co. Incorporated                        17     93K 
 2: EX-12       Statements Re Computation of Ratios                    2     15K 
 3: EX-13       Annual Report                                        128    761K 
 4: EX-21       Subsidiaries of J.P. Morgan                           10     32K 
 5: EX-23       Consent of Independent Accountants                     1      8K 
 6: EX-24       Powers of Attorney                                    18     44K 
 7: EX-27       Financial Data Schedule                                2±    13K 


EX-27   —   Financial Data Schedule



[Download Table] <ARTICLE> 9 <LEGEND> THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE CURRENT ANNUAL REPORT ON FORM 10-K FOR THE TWELVE MONTHS ENDED DECEMBER 31, 1999. AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENTS AND DISCLOSURES. </LEGEND> <MULTIPLIER> 1,000,000 <PERIOD-TYPE> 12-MOS <FISCAL-YEAR-END> DEC-31-1999 <PERIOD-START> JAN-01-1999 <PERIOD-END> DEC-31-1999 <CASH> 2,463 <INT-BEARING-DEPOSITS> 2,345 <FED-FUNDS-SOLD> 35,970<F1> <TRADING-ASSETS> 117,592 <INVESTMENTS-HELD-FOR-SALE> 0 <INVESTMENTS-CARRYING> 0 <INVESTMENTS-MARKET> 0 <LOANS> 26,849 <ALLOWANCE> 281 <TOTAL-ASSETS> 260,898 <DEPOSITS> 45,319 <SHORT-TERM> 81,805<F2> <LIABILITIES-OTHER> 98,085<F3> <LONG-TERM> 24,250 <PREFERRED-MANDATORY> 0 <PREFERRED> 694 <COMMON> 502 <OTHER-SE> 10,243 <TOTAL-LIABILITIES-AND-EQUITY> 260,898 <INTEREST-LOAN> 1,670 <INTEREST-INVEST> 1,588 <INTEREST-OTHER> 7,712 <INTEREST-TOTAL> 10,970 <INTEREST-DEPOSIT> 2,253 <INTEREST-EXPENSE> 9,429 <INTEREST-INCOME-NET> 1,541 <LOAN-LOSSES> (175)<F4> <SECURITIES-GAINS> 332<F5> <EXPENSE-OTHER> 5,742<F6> <INCOME-PRETAX> 3,114 <INCOME-PRE-EXTRAORDINARY> 2,055 <EXTRAORDINARY> 0 <CHANGES> 0 <NET-INCOME> 2,055 <EPS-BASIC> 11.16 <EPS-DILUTED> 10.39 <YIELD-ACTUAL> .85 <LOANS-NON> 77 <LOANS-PAST> 29 <LOANS-TROUBLED> 0 <LOANS-PROBLEM> 0 <ALLOWANCE-OPEN> 595<F7> <CHARGE-OFFS> 47<F7> <RECOVERIES> 33<F7> <ALLOWANCE-CLOSE> 406<F7> <ALLOWANCE-DOMESTIC> 30<F7> <ALLOWANCE-FOREIGN> 16<F7> <ALLOWANCE-UNALLOCATED> 360<F7> <FN> <F1>Includes securities purchased under agreements to resell and / or federal funds sold. <F2>Includes securities sold under agreements to repurchase and federal funds purchased, commercial paper, and other liabilities for borrowed money. <F3>Includes trading account liabilities, accounts payable and accrued expenses, other liabilities, and company-obligated mandatorily redeemable preferred securities of subsidiaries. <F4>Includes a reversal of provision for loan losses of ($175) million, and no provision for credit losses on lending commitments, recorded in Other revenue. <F5>Includes gain and losses on debt and equity investment securities, other-than-temporary impairments or write-downs in value, and related dividend income. <F6>Includes employee compensation and benefits, net occupancy, technology and communications, and other expenses. <F7>Amounts relate to the firm's allowance for loan losses and allowance for credit losses on lending commitments, such as commitments, standby letter of credit, and guarantees. The unallocated allowance represents our statistical estimate of probable loss inherent in our performing portfolio of traditional credit products, net of recoveries, determined in accordance with SFAS No. 5 (Our expected loss component). The allocated amounts represent our allowances to specific counterparties determined in accordance with SFAS No. 114 and SFAS No. 5, for loans and off-balance-sheet credit instruments, respectively. </FN>

Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘10-K’ Filing    Date    Other Filings
Filed on:3/8/00DEF 14A
For Period End:12/31/9913F-HR
 List all Filings 
Top
Filing Submission 0000950123-00-002072   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Fri., Mar. 29, 7:29:01.1am ET